Business Standard

Sunday, December 22, 2024 | 11:02 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

No issue with Covaxin certificate: Bharat Biotech on WHO suspending vaccine

Bharat biotech says there are no issues with Covaxin or its certification, further we will focus on pending facility maintenance, has no supply commitments pending for UN agency.

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Premium

Sohini Das Mumbai
Bharat Biotech said there were no issues with its Covid-19 vaccine or its certification, reacting after the World Health Organization (WHO) suspended supplies of Covaxin through United Nations agencies.

Covaxin certificates issued remain valid, as there is no impact on efficacy and safety of the vaccine, it said. Sources close to the development said the company had no further supply commitments to the WHO, and therefore, there was no suspension of any upcoming orders.

The WHO, however, asked Bharat Biotech to upgrade its production facilities, which the company will undertake now.

“It is like one was taking a sedan for

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in